Morning Breakouts

Latest KFF Health News Stories

Most States Becoming Engulfed In A Triple Whammy Of Delta, Omicron, Flu

Morning Briefing

In the first week of December, 841 people were admitted to U.S. hospitals with influenza, according to the Centers for Disease Control and Prevention. That’s up from the prior week, when there were 496 new flu admissions.

Moderna Vaccine Protection Is Lower Against Omicron; Booster Helps, Study Finds

Morning Briefing

Like the Pfizer mRNA shot, a preliminary study finds that the initial two-dose protocol of Moderna’s covid vaccine does not hold up against the omicron variant. But a booster dose can restore some of that effectiveness.

Why Is Omicron A Superspreader? New Data Offers Clues

Morning Briefing

The omicron variant has been found to infect 70 times faster than the delta or original covid strain — but causes less severe disease — in a study from the University of Hong Kong. Why? Researchers observed that the virus takes stronger hold in the airways rather than the lungs.

Omicron Spreads Globally, Expected To Be Dominant In EU In A Month

Morning Briefing

As omicron covid has spread to at least 77 countries and 35 U.S. states, the European Commission president said it was expected to dominate the area by mid-January. The CDC added Italy to the level 4 travel list, and German officials said the nation was tackling a vaccine supply problem.

San Francisco First US City To Mandate Paid Sick Leave For Nannies, Cleaners

Morning Briefing

The city’s board of supervisors passed the regulation Tuesday, assuring around 10,000 domestic workers would have paid sick leave. State child care issues in Rhode Island, debate over Georgia’s health proposals, a dangerous synthetic marijuana in Florida and more are also in the news.

Eye Drops That Can Replace Reading Glasses Arrive By Prescription

Morning Briefing

The New York Times reports that Vuity, a once-a-day eye drop treatment that can help users see close-by objects without making their vision short-sighted, is now available. Other news outlets report on forever chemical contaminations, Lyme disease, CTE in a shooting case and more.

Califf Garners Bipartisan Support During Senate Confirmation Hearing

Morning Briefing

Facing questions regarding opioids, abortion and drug pricing, Robert Califf testified before senators on his record and plans for the Food and Drug Administration. His nomination to head that agency is viewed to be on track after the two-hour session.

In New Abortion Plea To High Court, Arizona Seeks To Reinstate Penalties

Morning Briefing

Arizona’s law would impose criminal penalties on anyone performing an abortion because of genetic abnormalities in the fetus. Meanwhile, Wisconsin’s attorney general says if the Supreme Court overturns federal protections for the right to an abortion, he won’t prosecute under a state ban that would take effect.

San Francisco Exempts Gyms, Offices From California’s New Mask Rule

Morning Briefing

Meanwhile, Amtrak paused a vaccine mandate for employees over worries of service cuts if it had to terminate about 500 unvaxxed employees. Some Dallas hospitals are backing off vaccine mandates too. Kroger, on the other hand, is cutting some benefits for unvaccinated employees.

Idaho Deaths Reinforce Nursing Homes’ Ongoing Covid Vulnerability

Morning Briefing

Idaho’s health department released figures showing that 25% of its 1,000 covid deaths have been among residents living in nursing homes or long-term care facilities. State officials urge all caregivers to get vaccinated. News on covid spread at other health facilities is also reported.

J&J, Sinovac Shots Less Effective Against Omicron Covid

Morning Briefing

A lab test showed Johnson & Johnson’s shot led to “virtually no” antibody protection, and Sinovac’s shot (one of the most used around the world) doesn’t provide enough antibodies to neutralize the variant. Other covid news, including higher risk of myocarditis after infection, is also reported.

Pfizer’s Covid Pill Nearly 90% Effective Against Severe Illness

Morning Briefing

Media outlets cover news from Pfizer about final clinical trials of its covid treatment Paxlovid: the drug was 89% effective at preventing hospitalization and death. President Joe Biden has ordered enough of the pills to treat 10 million people.

Omicron Cases Prompt Cornell To Close Campus; Schools Brace For More Infections

Morning Briefing

As winter covid cases increase among college students, administrators are scrambling to respond with booster shot mandates and other mitigation measures. At Cornell University, 903 covid infections were reported between Dec. 7-13 — many of which were confirmed to be the omicron variant.

As Omicron’s Push Intensifies, Health Officials Fear Wave Of Cases In January

Morning Briefing

The pace of covid cases identified with the omicron variant jumped sevenfold in a single week, according to the CDC, and public health officials warn that hospitals that are already overwhelmed with delta cases in some states could become swamped.

Affordable Care Act Marketplace Enrollment Ends Today For Jan. 1 Start

Morning Briefing

Adjustments to health coverage or sign-ups will have to meet today’s deadline if coverage is to begin on Jan 1, 2022. Noticias Telemundo reports on efforts to enroll Latinos and, separately, Modern Healthcare covers news that 2022 is projected to be a positive year for big insurance companies.